Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant - Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping.

Van Malderen SCH, Daneels D, Kerkhove D, Peeters U, Theuns DAMJ, Droogmans S, Van Camp G, Weytjens C, Biervliet M, Bonduelle M, Van Dooren S, Brugada P.

Circ J. 2017 Aug 4. doi: 10.1253/circj.CJ-16-1279. [Epub ahead of print]


Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.


Clinical characteristics and short-term outcome of patients admitted with heart failure in Belgium: results from the BIO-HF registry.

De Sutter J, Pardaens S, Audenaert T, Weytjens C, Kerckhove BV, Willems RA, De Laet N, Van Camp G.

Acta Cardiol. 2015 Aug;70(4):375-85.


Prolonged right ventricular ejection delay identifies high risk patients and gender differences in Brugada syndrome.

Van Malderen SC, Kerkhove D, Theuns DA, Weytjens C, Droogmans S, Tanaka K, Daneels D, Van Dooren S, Meuwissen M, Bonduelle M, Brugada P, Van Camp G.

Int J Cardiol. 2015 Jul 15;191:90-6. doi: 10.1016/j.ijcard.2015.04.243. Epub 2015 May 1.


Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.


Prevalence, Determinants, and Prognostic Significance of Pulmonary Hypertension in Elderly Patients Admitted with Acute Decompensated Heart Failure: A Report from the BIO-HF Registry.

Vanhercke D, Pardaens S, Weytjens C, Vande Kerckhove B, De Laet N, Janssens E, Van Camp G, De Sutter J.

Echocardiography. 2015 Sep;32(9):1333-8. doi: 10.1111/echo.12857. Epub 2014 Dec 3.


Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.


Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.


Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.


Gender differences in the management and outcome of atrial fibrillation complicating acute heart failure.

Gevaert SA, de Bacquer D, Willems AM, Vande Kerckhove B, Weytjens C, van Camp G, de Sutter J.

J Card Fail. 2014 Jun;20(6):431-7. doi: 10.1016/j.cardfail.2014.03.004. Epub 2014 Mar 17.


Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.


Treatment of anemia with darbepoetin alfa in systolic heart failure.

Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators.

N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.


Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators.

Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.


Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.


Screening for silent myocardial ischaemia in patients with type 2 diabetes mellitus: a quest to improve selection of the target screening population.

De Keyzer E, Kerkhove D, Van Camp G, De Sutter J, Achtergael W, Keymeulen B, Weytjens C.

Acta Cardiol. 2011 Dec;66(6):715-20.


Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.

Dendale P, De Keulenaer G, Troisfontaines P, Weytjens C, Mullens W, Elegeert I, Ector B, Houbrechts M, Willekens K, Hansen D.

Eur J Heart Fail. 2012 Mar;14(3):333-40. doi: 10.1093/eurjhf/hfr144. Epub 2011 Nov 1.


Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure.

De Sutter J, Weytjens C, Van de Veire N, Provenier F, Vande Kerckhove B, Willems AM, De Laet N, Van Camp G.

Eur J Heart Fail. 2011 Apr;13(4):412-5. doi: 10.1093/eurjhf/hfq217. Epub 2010 Dec 7. No abstract available.


Evaluation of contractile function and inotropic reserve with tissue velocity, strain and strain rate imaging in streptozotocin-induced diabetes.

Weytjens C, Cosyns B, D'hooge J, Droogmans S, Lahoutte T, Garbar C, Roossens B, Van Camp G.

Eur J Echocardiogr. 2010 Aug;11(7):622-9. doi: 10.1093/ejechocard/jeq032. Epub 2010 Apr 17.


Analysis of regional wall motion during contrast-enhanced dobutamine stress echocardiography: effect of contrast imaging settings.

Cosyns B, Van Camp G, Droogmans S, Weytjens C, Schoors D, Lancellotti P.

Eur J Echocardiogr. 2009 Dec;10(8):956-60. doi: 10.1093/ejechocard/jep112. Epub 2009 Sep 22.


Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes.

Goethals LR, Weytjens CD, De Geeter F, Droogmans S, Caveliers V, Keyaerts M, Vanhove C, Van Camp G, Bossuyt A, Lahoutte T.

Contrast Media Mol Imaging. 2009 Jul-Aug;4(4):174-82. doi: 10.1002/cmmi.278.


Supplemental Content

Loading ...
Support Center